EQS-News: GeoVax Comments on FDA Approval of Keytruda (R) in Head and Neck Cancer, Underscoring Potential for Gedeptin (R) Combination Therapy

EQS-News: GeoVax Comments on FDA Approval of Keytruda (R) in Head and Neck Cancer, Underscoring Potential for Gedeptin (R) Combination Therapy — alphai